Locoregional GPC3 chimeric antigen receptor ( CAR)-T cell therapy is associated with improved tumor control in hepatocellular carcinoma by enhancing CAR-T cell trafficking and functionality

被引：0
|
作者：
Wang, Jue
Tsang, Kinching
Qiu, Jiale
Feng, Bo
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4011
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The Intersection between Chimeric Antigen Receptor T Cell (CAR-T) Therapy and the Kidneys: A Multicenter Study of Outcomes
    Matarneh, Ahmad
    Sardar, Sundus
    Portela, Rafael
    Abdulbasit, Muhammad
    Verma, Navin
    Trivedi, Naman
    Ghahramani, Nasrollah
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [42] Redefining chimeric antigen receptor T-cell (CAR-T) regulation: China's responses to address secondary cancer risks of CAR-T therapy
    Tan, Ruirong
    Li, Rui
    Dai, Meng-Yuan
    Liu, Miao
    Zhao, Junning
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2024, 17 (01)
  • [43] NEPHROTOXICITY OF CHIMERIC ANTIGEN RECEPTOR T CELL (CAR-T) THERAPY: ACUTE KIDNEY INJURY AND ELECTROLYTE DISORDERS
    Moncho Frances, Francesc
    Hernani Morales, Rafael
    Angel Solis, Miguel
    Benzaquen Vallejos, Ana
    Juan-Garcia, Isabel
    Hernandez Boluda, Juan Carlos
    Pinana Sanchez, Jose Luis
    Perez, Ariadna
    Gorriz Teruel, Jose Luis
    Torregrosa Maicas, Isidro Antonio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I1064 - I1065
  • [44] A Systematic Review of the Role of Chimeric Antigen Receptor T (CAR-T) Cell Therapy in the Treatment of Solid Tumors
    Siddiqui, Raheel S.
    Sardar, Muhammad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (04)
  • [45] Bispecific CAR-T cells targeting FAP and GPC3 have the potential to treat hepatocellular carcinoma
    Zhou, Linfu
    Li, Yao
    Zheng, Diwei
    Zheng, Yongfang
    Cui, Yuanbin
    Qin, Le
    Tang, Zhaoyang
    Peng, Dongdong
    Wu, Qiting
    Long, Youguo
    Yao, Yao
    Wong, Nathalie
    Lau, James
    Li, Peng
    MOLECULAR THERAPY ONCOLOGY, 2024, 32 (02):
  • [46] Chimeric Antigen Receptor T Cell (CAR-T) Therapy Outcomes In Rheumatological Autoimmune Disorders: A Systematic Review
    Zulfiqar, Fizza
    Shahzad, Moazzam
    Vyas, Abhinav
    Sarfraz, Zouina
    Zainab, Anika
    Qasim, Hana
    Kaur, Dania
    Khavandgar, Naghmeh
    Amin, Kashif
    Ahmed, Nausheen
    Abdallah, Al-Ola
    Lutfi, Forat
    Hematti, Peiman
    Singh, Anurag K.
    McGuirk, Joseph P.
    Mushtaq, Muhammad Umair
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S589 - S589
  • [47] Intrathecal Chemotherapy As Treatment for Chimeric Antigen Receptor T Cell (CAR T) Therapy Associated Neurotoxicity
    Solh, Melhem M.
    Bashey, Asad
    Morris, Lawrence
    Bachier-Rodriguez, Lizamarie
    Holland, H. Kent
    Zhang, Xu
    Jackson, Katelin C.
    Solomon, Scott R.
    BLOOD, 2023, 142
  • [48] Intrathecal chemotherapy as treatment for chimeric antigen receptor T cell (CAR T) therapy associated neurotoxicity
    Bashey, Saffiya Z.
    Solomon, Scott R.
    Zhang, Xu
    Morris, Lawrence E.
    Holland, H. Kent
    Bachier, Lizamarie
    Patel, Krishi
    Solh, Melhem M.
    BONE MARROW TRANSPLANTATION, 2024, 59 (12) : 1783 - 1785
  • [49] Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
    Ajeet Gajra
    Abigail Zalenski
    Aishwarya Sannareddy
    Yolaine Jeune-Smith
    Kandice Kapinos
    Ankit Kansagra
    Pharmaceutical Medicine, 2022, 36 : 163 - 171
  • [50] Barriers to Chimeric Antigen Receptor T-Cell (CAR-T) Therapies in Clinical Practice
    Gajra, Ajeet
    Zalenski, Abigail
    Sannareddy, Aishwarya
    Jeune-Smith, Yolaine
    Kapinos, Kandice
    Kansagra, Ankit
    PHARMACEUTICAL MEDICINE, 2022, 36 (03) : 163 - 171
12345